AXGN FY 2025 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$225M+20.2% YoY

Gross Profit

$167M74.3% margin

Operating Income

-$8M-3.5% margin

Net Income

-$16M-7.0% margin

EPS (Diluted)

$-0.34

Cash Flow

Operating Cash Flow

$812,000

Free Cash Flow

-$3M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$222M

Total Liabilities

$93M

Stockholders' Equity

$129M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$225M	$187M	+20.2%
Gross Profit	$167M	$142M	+17.9%
Operating Income	-$8M	-$3M	-138.8%
Net Income	-$16M	-$10M	-57.6%